Skip to main content
Tobias Hohl, MD, Infectious Disease, New York, NY

TobiasMartinHohlMD

Infectious Disease • New York, NY

Assistant Professor, Medicine, University of Washington School of Medicine

Join to view full profile

Dr. Hohl is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Hohl's full profile

Already have an account?

  • Office

    530 East 74th Street
    New York, NY 10021

Education & Training

  • Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer CenterFellowship, Infectious Disease, 2003 - 2007
  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2001 - 2003
  • Weill Cornell Medicine
    Weill Cornell MedicineClass of 2001

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2002 - 2026
  • WA State Medical License
    WA State Medical License 2008 - 2015
  • Infectious Disease
    American Board of Internal Medicine Infectious Disease

Publications & Presentations

PubMed

Journal Articles

  • Response to Comment on “Sterilizing Immunity in the Lung Relies on Targeting Fungal Apoptosis-like Programmed Cell Death”  
    Tobias Hohl, MD, Science Magazine

Press Mentions

  • Cancer Patients May Be at Greater Risk of Death from COVID-19
    Cancer Patients May Be at Greater Risk of Death from COVID-19October 4th, 2022
  • Dangerous Fungal Lung Infections Could Be Treated with CAR T-cells
    Dangerous Fungal Lung Infections Could Be Treated with CAR T-cellsSeptember 28th, 2022
  • Antibiotics Induce Invasive Candidiasis in Mice and Humans, Immunotherapy Could Help
    Antibiotics Induce Invasive Candidiasis in Mice and Humans, Immunotherapy Could HelpMay 16th, 2022
  • Join now to see all

Grant Support

  • Initiation Of The Immune Response To Aspergillus FumigatusNational Institute Of Allergy And Infectious Diseases2011
  • Monocyte-Mediated Host Defense Against Aspergillus FumigatusNational Institute Of Allergy And Infectious Diseases2009–2010
  • Monocyte-Mediated Host Defense Against Aspergillus FumigatusNational Institute Of Allergy And Infectious Diseases2008–2009

Dr. Tobias Hohl, Dr. Tobias Hohl, MD, Dr. T Hohl, Dr. Tobias Martin Hohl